Close

Articles Posted in Dangerous Drugs

Updated:

Johnson & Johnson Discontinues Talcum-Based Baby Powder Worldwide

Johnson & Johnson will stop selling its popular talc-based baby powder globally starting next year, according to a corporate statement released in August. The multinational healthcare conglomerate had already discontinued talc-based baby powder in the U.S. and Canada in 2020, but will now transition to cornstarch-based powder worldwide. Although the…

Updated:

Claims of addiction due to Juul products

Altman & Altman LLP is actively reviewing claims regarding cases of nicotine addiction that have occurred due to the widespread use of Juul brand vaporizers. Specifically, we are pursuing claims from individuals who used a Juul vaporizer before they were 18 years of age, and used it prior to November…

Updated:

$28 Million Verdict in Xarelto Lawsuit

A Philadelphia woman was awarded nearly $28 million for injuries she suffered while taking the anti-coagulant medication, Xarelto. The blood thinner, manufactured by Johnson & Johnson and Bayer AG, is linked to serious health risks, including excessive bleeding and death. Lynn Hartman claims to have been taking Xarelto for more…

Updated:

Johnson & Johnson to pay out $1 billion for faulty hip implants

Pharmaceutical giant Johnson & Johnson (J&J) has been ordered by a Texas federal jury to pay out over $1 billion in punitive and compensatory damages after a lengthy trial ultimately decided in the favor of six plaintiffs who claimed to have suffered severe consequences after being fitted with J&J’s “Pinnacle”…

Updated:

Johnson & Johnson to Pay $70.1 Million to Ovarian Cancer Victim

Another jury has concluded that talcum powder does, indeed, cause ovarian cancer. This multimillion-dollar verdict is the third of its kind for Johnson & Johnson this year. Deborah Giannecchini of Modesto, California, was awarded more than $70 million last week, as a result of her 2012 ovarian cancer diagnosis. According…

Contact Us
Start Chat